Compare ABCL & AGYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | AGYS |
|---|---|---|
| Founded | 2012 | 1963 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.1B |
| IPO Year | 2020 | 1994 |
| Metric | ABCL | AGYS |
|---|---|---|
| Price | $12.61 | $100.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $8.40 | ★ $111.67 |
| AVG Volume (30 Days) | ★ 4.4M | 173.4K |
| Earning Date | 05-11-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.91 | ★ 67.07 |
| EPS | N/A | ★ 0.32 |
| Revenue | $75,128,000.00 | ★ $319,312,000.00 |
| Revenue This Year | N/A | $17.65 |
| Revenue Next Year | $21.85 | $14.36 |
| P/E Ratio | ★ N/A | $313.28 |
| Revenue Growth | ★ 160.56 | 15.85 |
| 52 Week Low | $2.75 | $61.50 |
| 52 Week High | $13.18 | $144.82 |
| Indicator | ABCL | AGYS |
|---|---|---|
| Relative Strength Index (RSI) | 65.97 | 37.61 |
| Support Level | $10.38 | $94.74 |
| Resistance Level | N/A | $114.23 |
| Average True Range (ATR) | 0.61 | 3.73 |
| MACD | -0.01 | -1.43 |
| Stochastic Oscillator | 79.02 | 11.17 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Agilysys Inc is engaged in hospitality software, delivering cloud-native SaaS and on-premise solutions for hotels, multi-amenity resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It operates across the Americas, Europe, the Middle East, Africa, Asia-Pacific, and India with headquarters located in Alpharetta, GA. The Company has one reportable segment serving the global hospitality industry.